Julie Schanz

Julie Schanz

UNVERIFIED PROFILE

Are you Julie Schanz?   Register this Author

Register author
Julie Schanz

Julie Schanz

Publications by authors named "Julie Schanz"

Are you Julie Schanz?   Register this Author

29Publications

1073Reads

46Profile Views

Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib.

Leuk Lymphoma 2016 10 25;57(10):2476-80. Epub 2016 Feb 25.

a Department of Haematology and Medical Oncology , University Medicine Goettingen , Goettingen , Germany ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1151510DOI Listing
October 2016

Helpful Tool or Oversimplification? Concept of the Monosomal Karyotype from the Clinical and Cytogenetic Point of View.

Authors:
Julie Schanz

Biol Blood Marrow Transplant 2016 Feb 22;22(2):191-192. Epub 2015 Nov 22.

University Medicine of Goettingen. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.11.013DOI Listing
February 2016

New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes.

Genes Chromosomes Cancer 2015 Dec 23;54(12):717-24. Epub 2015 Sep 23.

Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.22282
Publisher Site
http://dx.doi.org/10.1002/gcc.22282DOI Listing
December 2015

Primary osteomyelofibrosis and an XX-male genotype.

Eur J Haematol 2015 Sep 5;95(3):254-6. Epub 2015 May 5.

Department of Hematology and Oncology, St. Josefs-Hospital, Cloppenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12555DOI Listing
September 2015

Rare cytogenetic abnormalities in myelodysplastic syndromes.

Mediterr J Hematol Infect Dis 2015 1;7(1):e2015034. Epub 2015 May 1.

Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2015.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418404PMC
May 2015

Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.

Leuk Res 2011 Jun 26;35(6):834-6. Epub 2011 Jan 26.

Department of Pathology, Hospital del Mar, GRETNHE, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.01.003DOI Listing
June 2011

Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes.

Leuk Res 2009 Sep 2;33(9):1183-8. Epub 2009 May 2.

Georg-August-University, Department of Haematology and Oncology, Robert-Koch-Str. 40, 37075 Goettingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.03.027DOI Listing
September 2009